E, Sanger sequencing analysis of the tumor C-12A and C-12B Deletion PCR products. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. F, PCR was performed with a primer set designed for isolation of Duplication 1 (illustrated in A and B) using DNA from tumors C-12A and C-12B as well as LNCaP or no template control (NTC) as negative controls. G, Sanger sequencing analysis of the tumor C-12A and C-12B Duplication 1 PCR products. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. The 3' breakpoint sequence is located in a LINE-1 element H, PCR was performed with a primer set designed for isolation of Duplication 2 (illustrated in A and B) using DNA from tumor C-12A as well as LNCaP or no template control (NTC) as negative controls. I, Sanger sequencing analysis of the tumor C-12A Duplication 2 PCR product. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. The 3' breakpoint sequence is located in a LINE-1 element. J, PCR was performed with a primer set designed for isolation of Duplication 3 (illustrated in A and B) using DNA from tumor C-12A as well as LNCaP or no template control (NTC) as negative controls. K, Sanger sequencing analysis of the tumor C-12B Duplication 3 PCR product. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. The 3' breakpoint sequence is located in a LINE-1 element.
Supplementary Figure 7.
AR genomic structural rearrangement validation in subject C-14. A and B, binding locations of PCR primers (colored arrowheads) for validation of Inversions 1, 2, and 3, and the Duplication in tumors C-14A and C-14B. C, AR DNA-seq coverage for tumors C-14A and C-14B was assessed by visualizing BAM files of mapped AR DNA-seq reads in Integrative Genomics Viewer. D, PCR was performed with a primer set designed for isolation of Inversion 1 (illustrated in A and B) using DNA from tumors C-14A and C-14B as well as LNCaP DNA and no template control (NTC) as negative controls. E, Sanger sequencing analysis of the tumor C-14A Inversion 1 PCR product. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. The 5' breakpoint sequence is located in a LINE-1 element F, PCR was performed with a primer set designed for isolation of Inversion 2 (illustrated in A and B) using DNA from tumors C-14A and C-14B as well as LNCaP or no template control (NTC) as negative controls. G, Sanger sequencing analysis of the tumor C-14A Inversion 1 PCR product. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. H, PCR was performed with a primer set designed for isolation of Inversion 3 (illustrated in A and B) using DNA from tumor C-14B as well as LNCaP or no template control (NTC) as negative controls. I, Sanger sequencing analysis of the tumor C-14B Inversion 3 PCR product. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. J, PCR was performed with a primer set designed for isolation of the Duplication (illustrated in A and B) using DNA from tumor C-14B as well as LNCaP or no template control (NTC) as negative controls. K, Sanger sequencing analysis of the tumor C-14B Duplication PCR product. The genomic sequences corresponding to the 5' and 3' breakpoints are indicated, with gray shading representing the sequences contained in the break fusion junction signature. The 5' breakpoint sequence is located in a LINE-1 element. ChxX:66939745 C-6B SAME AS C-6A SAME AS C-6A C-6C SAME AS C-6A SAME AS C-6A C-7A 
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